Multiple Interactions of IgG with Its Core Oligosaccharide Can Modulate Recognition by Complement and Human Fcγ Receptor I and Influence the Synthesis of Its Oligosaccharide Chains

Journal of Immunology

Volumn 157, Issue 11, 1996, Pages 4963-4969

  Lund, John ^a,c   Takahashi, Noriko ^b   Pound, John D ^a   Goodall, Margaret ^a   Jefferis, Royston ^a  

^a MRC Centre for Immune Regulation   (United Kingdom)

^b Nakano Vinegar Co Ltd   (Japan)

^c Medical School   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; FC RECEPTOR; HYBRID PROTEIN; IMMUNOGLOBULIN G; OLIGOSACCHARIDE;

ANIMAL; ARTICLE; BINDING SITE; BIOSYNTHESIS; CARBOHYDRATE ANALYSIS; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; GLYCOSYLATION; HAMSTER; HUMAN; IN VITRO STUDY; METABOLISM; MOLECULAR GENETICS; MOUSE; PROTEIN CONFORMATION; PROTEIN ENGINEERING;

ANIMALS; BINDING SITES; CARBOHYDRATE SEQUENCE; CELL LINE; COMPLEMENT SYSTEM PROTEINS; CRICETINAE; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; OLIGOSACCHARIDES; PROTEIN CONFORMATION; PROTEIN ENGINEERING; RECEPTORS, IGG; RECOMBINANT FUSION PROTEINS;

EID: 0030470557     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Jefferis, R., and J. Lund. 1993. Molecular characterization of IgG antibody Fc effector sites. In Protein Engineering of Antibody Molecules for Prophylactic and Therapeutic Applications in Man. M. Clarke, ed. Academic Titles, Nottingham, U.K., p. 115.
2. Deisenhofer, J. 1981. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment b of protein A from Staphylococcus aureus at 2.9- and 2.8-Å resolution. Biochemistry 20:2361.
3. Padlan, E. 1991. X-ray diffraction studies of antibody constant regions. In Fc Receptors and the Action of Antibodies. H. Metzger, ed. American Society for Microbiology, Washington, DC, p. 12.
4. Lund, J., N. Takahashi, J. D. Pound, H. Nakagawa, M. Goodall, and R. Jefferis. 1995. Oligosaccharide-protein interactions in IgG can modulate recognition by Fcγ receptors. FASEB J. 116:115.
5. Duncan, A., and G. Winter. 1988. The binding site for C1q on IgG. Nature 332:738.
6. H2 domain and is modulated by the hinge region. J. Exp. Med. 173:1483.
7. Lund, J., G. Winter, P. T. Jones, J. D. Pound, T. Tanaka, M. Walker, P. J. Artymiuk, Y. Arata, D. R. Burton, R. Jefferis, and J. M. Woof. 1991. Human FcγRI and FcγRII interact with distinct but overlapping binding sites on human IgG. J. Immunol. 147:2657.
8. H2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, FcγRI and FcγRIII binding. Immunology 86:319.
9. Tao, M.-H., R. I. F., Smith, and S. L. Morrison. 1993. Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation. J. Exp. Med. 178:661.
10. Tao, M.-H., and S. L. Morrison. 1989. Studies of aglycosylated chimeric mouse-human IgG: role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J. Immunol. 143:2595.
11. Walker, M. R., J. Lund, K. M. Thompson, and R. Jefferis. 1989. Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing FcγRI and/or FcγRII. Biochem. J. 259:347.
12. Hindley, S., Y. Gao., P. Nash, C. Sautes, J. Lund, M. Goodall, and R. Jefferis. 1993. The interaction of IgG with FcγRII: involvement of the lower hinge binding site as probed with NMR. Biochem. Soc. Trans. 21:337S.
13. Lund, J., T. Tanaka, N. Takahashi, G. Sarmay, Y. Arata, and R. Jefferis. 1990. A protein structural change in aglycosylated IgG3 correlates with loss of huFcγRI and FcγRIII binding and/or activation. Mol. Immunol. 27:1145.
14. Lund, J., N. Takahashi, H. Nakagawa, T. Bentley, S. Hindley, R. Tyler, M. Goodall, and R. Jefferis. 1993. Control of IgG-Fc glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs. Mol. Immunol. 30:741.
15. Wright, A., M.-H. Tao, E. A. Kabat, and S. L. Morrison. 1991. Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure. EMBO J. 10:2717.
16. Endo, T., A. Wright, S. L. Morrison, and A. Kobata. 1995. Glycosylation of the variable region of immunoglobulin G-site specific maturation of the sugar chains. Mol. Immunol. 32:934.
17. Morton, C., J. D. Atkin, R. J. Owens, and J. M. Woof. 1993. Purification and characterization of chimeric human IgA1 and IgA2 expressed in COS and chinese hamster ovary cells. J. Immunol. 151:4743.
18. Klerx, J. P. A. M., C. J. Verplanke, C. G. Blonk, and L. C. Twaalfhoven. 1988. In vitro production of monoclonal antibodies under serum-free conditions using a compact and inexpensive hollow fibre cell culture unit. J. Immunol. Methods 111:179.
19. Hudson, L., and F. C. Hay. 1989. Practical Immunology. 3rd Ed. Blackwell, London, p. 494.
20. Pound, J. D., J. Lund, and R. Jefferis. 1993. Aglycosylated chimeric human IgG3 can trigger the human phagocyte respiratory burst. Mol. Immunol. 30:233.
21. Takahashi, N., H. Nakagawa, K. Fujikawa, Y. Kawamura, and N. Tomiya. 1995. Three dimensional elution mapping of pyridylaminated N-linked neutral and sialyl oligosaccharides. Anal. Biochem. 226:139.
22. Yamamoto, S., S. Hase, S. Fukuda, O. Sano, and T. Ikenaka. 1989. Structures of the sugar chains of interferon-γ produced by human myelomonocyte cell line HBL-38. J. Biochem. 105:547.
23. Tomiya, N., J. Awaya, M. Kurono, S. Endo, Y. Arata, and N. Takahashi. 1988. Analyses of N-linked oligosaccharides using a two-dimensional mapping technique. Anal. Biochem. 171:73.
24. Francois, C., R. D. Marshall, and A. Neuberger. 1962. Carbohydrates in protein 4: the determination of mannose in hen's egg albumin by radioisotope dilution. Biochem. J. 83:335.
25. Nik-Jafaar, M. I., J. A. Lowe, N. R. Ling, and R. Jefferis. 1984. Immunogenic and antigenic epitopes of immunoglobulins VII: the topographical distribution of Fcγ epitopes and the relationship of an iso-allotypic specificity to the presence of histidine 435. Mol. Immunol. 21:137.
26. Jefferis, R., C. B. Reimer, F. Skvaril, G. de Lange, N. R. Ling, J. Lowe, M. R. Walker, D. J. Phillips, C. H. Aloisio, T. W. Wells, J. P. Vaerman, C. G. Magnusson, H. Kubagawa, M. Cooper, F. Vartdal, B. Vandvik, J. J. Haaijman, O. Makela, A. Sarnesto, Z. Lando, J. Gergely, E. Rajnavölgyi, G. László, J. Radl, and G. A. Molinaro. 1985. Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study. Immunol. Lett. 10:223.
27. Hussain, R., R. W. Poindexter, R. Wistar, and C. B. Reimer. 1986. Use of monoclonal antibodies to quantify subclasses of human IgG. I. Development of two-site immunoenzymatic assays for total IgG subclass determinations. J. Immunol. Methods 93:89.
28. Jefferis, R., C. Reimer, F. Skvaril, and G. de Lange. 1988. WHO/IUIS programme for the standardization of immunological reagents; availability of mouse monoclonal antibodies (mAb) to human IgG subclasses. Immunology 63:171.
29. Nelson, P. N., S. M. Fletcher, G. G. de Lange, A. M. van Leeuwen, M. Goodall, and R. Jefferis. 1990. Evaluation of monoclonal antibodies with putative specificity for human IgG allotypes. Vox Sang. 59:190.
30. Dwek, R. A. 1995. Towards understanding the function of sugars. Biochem. Soc. Trans. 23:1.
31. Koolwijk, P., G. T. Spierenberg, H. Frasa, J. H. A. Boot, J. G. J. van de Winkel, and B. J. E. G. Bast. 1989. Interaction between hybrid mouse monoclonal antibodies and the human high-affinity IgG FcR, huFcγRI, on U937. J. Immunol. 143:1656.
32. Tsuchiya, N., T. Endo, K. Matsuta, S. Yoshinoya, T. Aikawa, E. Kosuge, F. Takeuchi, T. Miyomoto, and A. Kobata. 1989. Effects of galactose depletion from oligosaccharide chains on immunological activities of human IgG. J. Rheumatol. 16:285.
33. Boyd, P. N., A. C. Lines, and A. K. Patel. 1995. The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of CAMPATH-1H. Mol. Immunol. 32:1311.
34. H2 associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin 1. J. Exp. Med. 180:1087.